| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | $26.2M | 6.4M | ▲+9.6% Added · +556K sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $17.6M | 4.3M | ▲+4.8% Added · +195K sh | Q1 2026 | |
| 3 | BRAIDWELL LP | $12.8M | 3.1M | —Held | Q1 2026 | |
| 4 | Frazier Life Sciences Management, L.P. | $10.8M | 2.6M | —Held | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $10.2M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 6 | Soleus Capital Management, L.P. | $9.2M | 2.2M | ▲+110% Added · +1.2M sh | Q1 2026 | |
| 7 | MILLENNIUM MANAGEMENT LLC | $6.0M | 1.5M | ▼−30% Reduced · −632K sh | Q1 2026 | |
| 8 | ARMISTICE CAPITAL, LLC | $5.7M | 1.4M | ▲+43% Added · +420K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $5.7M | 1.4M | ▼−0.3% Reduced · −5K sh | Q1 2026 | |
| 10 | STATE STREET CORP | $5.4M | 1.3M | ▼−16% Reduced · −254K sh | Q1 2026 | |
| 11 | PERCEPTIVE ADVISORS LLC | $5.3M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 12 | RICE HALL JAMES & ASSOCIATES, LLC | $5.2M | 1.3M | ▲+8.8% Added · +101K sh | Q1 2026 | |
| 13 | PINNACLE ASSOCIATES LTD | $4.8M | 1.2M | ▲+48% Added · +377K sh | Q1 2026 | |
| 14 | GOLDMAN SACHS GROUP INC | $4.5M | 1.1M | ▲+210% Added · +736K sh | Q1 2026 | |
| 15 | UBS Group AG | $3.1M | 753K | ▼−15% Reduced · −128K sh | Q1 2026 | |
| 16 | CITADEL ADVISORS LLC | $2.9M | 697K | ▼−49% Reduced · −683K sh | Q1 2026 | |
| 17 | AWH Capital, L.P. | $2.6M | 625K | —Held | Q1 2026 | |
| 18 | D. E. Shaw & Co., Inc. | $2.3M | 559K | ▼−64% Reduced · −982K sh | Q1 2026 | |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.1M | 516K | ▼−0.3% Reduced · −2K sh | Q1 2026 | |
| 20 | TANG CAPITAL MANAGEMENT LLC | $2.0M | 483K | ▼−61% Reduced · −763K sh | Q1 2026 | |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.0M | 477K | ▲New +477K sh | Q1 2026 | |
| 22 | NORTHERN TRUST CORP | $1.9M | 472K | ▲+6.1% Added · +27K sh | Q1 2026 | |
| 23 | STIFEL FINANCIAL CORP | $1.9M | 458K | ▲+74% Added · +195K sh | Q1 2026 | |
| 24 | DEUTSCHE BANK AG\ | $1.8M | 442K | ▲+1.1% Added · +5K sh | Q1 2026 | |
| 25 | VANGUARD FIDUCIARY TRUST CO | $1.7M | 425K | ▲New +425K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 47 funds | $5.0B |
| NEUROCRINE BIOSCIENCES INCNBIX | 47 funds | $386.5M |
| NVIDIA CORPNVDA | 46 funds | $32.3B |
| MICROSOFT CORPMSFT | 46 funds | $20.5B |
| CVS HEALTH CORPCVS | 46 funds | $931.5M |
| BIOGEN INCBIIB | 46 funds | $191.2M |
| APPLE INCAAPL | 45 funds | $23.1B |
| META PLATFORMS INC-CLASS AMETA | 45 funds | $9.1B |
| JPMORGAN CHASE & COJPM | 45 funds | $6.5B |
| COSTCO WHOLESALE CORPCOST | 45 funds | $3.5B |
| WALMART INCWMT | 45 funds | $3.3B |
| UNITEDHEALTH GROUP INCUNH | 45 funds | $2.1B |
Ranked by how many of EOLS's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | MOATAZEDI DAVID | See Remarks, Director | Sell (S) | 14K | $65K |
| Mar 20, 2026 | Avelar Rui | See Remarks | Sell (S) | 3K | $15K |
| Mar 17, 2026 | Avelar Rui | See Remarks | Sell (S) | 30K | $147K |
| Mar 17, 2026 | MOATAZEDI DAVID | See Remarks, Director | Sell (S) | 117K | $571K |
| Dec 22, 2025 | Avelar Rui | See Remarks | Sell (S) | 2K | $16K |
| Dec 22, 2025 | MOATAZEDI DAVID | See Remarks, Director | Sell (S) | 11K | $75K |
| Aug 22, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell (S) | 6K | $43K |
| Aug 15, 2025 | Stewart Brady | Director | Buy (P) | 30K | $205K |
| Jun 16, 2025 | MOATAZEDI DAVID | See Remarks, Director | Sell (S) | 17K | $164K |
| Jun 13, 2025 | MOATAZEDI DAVID | See Remarks, Director | Sell (S) | 111K | $1.1M |
| Jun 9, 2025 | White Albert G III | Director | Buy (P) | 20K | $189K |
| May 13, 2025 | Beaver Sandra | Chief Financial Officer | Sell (S) | 6K | $65K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/EOLS/capital-change-brief"
Use Arkolith's capital_change_brief for EOLS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for EOLS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.